Ceva creates 60 strong teams to support innovative vaccination services on farm and in the hatchery >
Recent research showed Ceva that their customers want more than just good vaccines; they want 100% of their birds correctly vaccinated.
Ceva enter global partnership to improve Cat Care >
Partnership between International Cat Care and Ceva will work closely to promote the benefits of cat ownership
New Technology Vaccine Symposium - Miami >
Ceva shares global field experiences through New Technology Vaccine Symposium held in the US. Innovation in the hatchery will drive productivity gains
Ceva Welfare Awards – Winners announcement >
2nd Annual Ceva Animal Welfare Awards, celebrating the contributions to the prevention and reduction of animal welfare problems in the UK and abroad.
Ceva records double digit growth for 3rd. successive year >
14% growth pushes sales beyond 600 M€ for first time
Ceva presents a complete range of vector vaccines at IPE 2013 >
Vectormune® ND and Transmune® IBD, “The Perfect Pair” of vaccines for Gumboro and Newcastle prevention can now be administered in one injection at the hatchery.
Ceva announces scientific breakthrough with the launch of Vectormune® AI >
Vectormune® AI a new generation vaccine for the control of Avian Influenza.
AXA Private Equity provides additional financing to support the development of Ceva >
AXA Private Equity, the leading European diversified private equity firm, announces today that it is providing €100 million of additional financing to support the development of Ceva.
Ceva launches CARDALIS® for dogs with heart failure >
A powerful dual treatment in a single tablet
The Perfect Pair is now available >
A great innovation in the protection against Newcastle and Gumboro Diseases